Medical Polyoxymethylene Market Is Expected To Reach Revenue Of USD 253.5 Mn By 2033, at 7.4 % CAGR: Dimension Market Research
May 22, 2024 12:49 ET
|
Dimension Market Research
New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview The Medical Polyoxymethylene Market size is expected to reach USD 133.6 million by 2024 and is further anticipated to value USD 253.5...
Global Neodymium-Iron-Boron Magnet Market Report 2024: A $ 28.1 Billion Market by 2032, Exhibiting a Growth Rate (CAGR) of 6.76% During 2023-2032
May 21, 2024 04:05 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Global Neodymium-Iron-Boron Magnet Market Report by Application, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
May 20, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new...
Southeast Detox GA: Award Winning Suboxone Treatment Center in Rome, GA
May 16, 2024 09:00 ET
|
Southeast Detox GA
Rome, GA, May 16, 2024 (GLOBE NEWSWIRE) -- Southeast Detox GA, a leading inpatient alcohol and drug addiction rehab center, is excited to announce that its Rome Georgia in-patient detox facility has...
Venture Partnership: Leading Medical Recruitment Agency Secures Coveted Framework Award
May 15, 2024 09:00 ET
|
Venture Partnership
Uxbridge, England, May 15, 2024 (GLOBE NEWSWIRE) -- Venture Partnership, a leading recruitment agency focused on providing permanent and locum doctor staffing solutions to the primary, acute, and...
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
May 13, 2024 20:22 ET
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
May 09, 2024 14:51 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
RTI Connext® Named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program
May 09, 2024 10:00 ET
|
Real-Time Innovations (RTI)
RTI Connext® named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program.
SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
May 08, 2024 07:15 ET
|
SchooLinks
Austin, TX, May 08, 2024 (GLOBE NEWSWIRE) -- SchooLinks, the most innovative platform for college and career readiness, is proud to announce its recent achievements in both business growth and...